grazoprevir,
grazoprevir anhydrous,
grazoprevir monohydrate,
MK 5172,
MK-5172,
MK5172,
Grazoprevir hydrate,
MK-5172 (hydrate),
UNII-4O2AB118LA,
Grazoprevir [USAN],
1350462-55-3,
MK-5172 hydrate,
4O2AB118LA,
Grazoprevir (USAN),
MK 5172,
Grazyna (TN),
Grazoprevir monohydrate,
Grazoprevir hydrate (JAN),
CHEMBL3039533,
SCHEMBL18259662,
DTXSID00159229,
HY-15298B,
AKOS030526434,
CS-1376,
D10639,
W-6089,
Grazoprevir hydrate;MK5172 hydrate;MK 5172 hydrate,
(1aR,5S,8S,10R,22aR)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl)-5-(1,1-dimethylethyl)-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa(18,19)(1,10,3,6)dioxadiazacyclononadecino(11,12-b)quinoxaline-8-carboxamide hydrate,
Cyclopropanecarboxamide, N-((((1R,2R)-2-(5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1->2)-ether, hydrate (1 :1) (1R,2S)-,
Grazoprevir,
MK-5172,